All Videos Channels
  2. Dapagliflozin, a type 2 diabetes medication, has shown potential benefits post myocardial infarction

    Dapagliflozin, a type 2 diabetes medication, has shown potential benefits post myocardial infarction

    22
  4. SGLT2i EXTEND LIFE IN NON-DIABETIC CKD! || SSRIs & Nicotine || NAFLD & Heart Disease || Biomarkers

    SGLT2i EXTEND LIFE IN NON-DIABETIC CKD! || SSRIs & Nicotine || NAFLD & Heart Disease || Biomarkers

    56
  5. SGLT2 inhibitors Dapagliflozin have shown positive effects on the human heart.

    SGLT2 inhibitors Dapagliflozin have shown positive effects on the human heart.

    70